The economic impact of the transition from branded to generic oncology drugs.
Cheung WY, Kornelsen EA, Mittmann N, Leighl NB, Cheung M, Chan KK, Bradbury PA, Ng RCH, Chen BE, Ding K, Pater JL, Tu D, Hay AE.
Cheung WY, et al. Among authors: cheung m.
Curr Oncol. 2019 Apr;26(2):89-93. doi: 10.3747/co.26.4395. Epub 2019 Apr 1.
Curr Oncol. 2019.
PMID: 31043808
Free PMC article.